| Structural basis for PAS domain heterodimerization in the basic helix–loop–helix-PAS transcription factor hypoxia-inducible factor PJA Erbel, PB Card, O Karakuzu, RK Bruick, KH Gardner Proceedings of the National Academy of Sciences 100 (26), 15504-15509, 2003 | 271 | 2003 |
| Synergistic interaction of paclitaxel and curcumin with cyclodextrin polymer complexation in human cancer cells AO Boztas, O Karakuzu, G Galante, Z Ugur, F Kocabas, CZ Altuntas, ... Molecular pharmaceutics 10 (7), 2676-2683, 2013 | 122 | 2013 |
| Amplex red assay for measuring hydrogen peroxide production from Caenorhabditis elegans O Karakuzu, MR Cruz, Y Liu, DA Garsin Bio-protocol 9 (21), e3409-e3409, 2019 | 38 | 2019 |
| unc-3-dependent repression of specific motor neuron fates in Caenorhabditis elegans B Prasad, O Karakuzu, RR Reed, S Cameron Developmental biology 323 (2), 207-215, 2008 | 32 | 2008 |
| MIG-32 and SPAT-3A are PRC1 homologs that control neuronal migration in Caenorhabditis elegans O Karakuzu, DP Wang, S Cameron Oxford University Press for The Company of Biologists Limited 136 (6), 943-953, 2009 | 27 | 2009 |
| A multifunctional nanoparticulate theranostic system with simultaneous chemotherapeutic, photothermal therapeutic, and MRI contrast capabilities M Zhang, T Yilmaz, AO Boztas, O Karakuzu, WY Bang, Y Yegin, Z Luo, ... RSC advances 6 (33), 27798-27806, 2016 | 22 | 2016 |
| Tribbles pseudokinase NIPI-3 regulates intestinal immunity in Caenorhabditis elegans by controlling SKN-1/Nrf activity C Wu, O Karakuzu, DA Garsin Cell reports 36 (7), 2021 | 20 | 2021 |
| Redox-dependent and redox-independent functions of Caenorhabditis elegans thioredoxin 1 Á Sanzo-Machuca, JMM Moreno, R Casado-Navarro, O Karakuzu, ... Redox Biology 24, 101178, 2019 | 7 | 2019 |
| Targeting innate immunity with BXCL701 in combination with pembrolizumab in patients with advanced solid cancers: Phase 2 basket study. O Karakuzu, AM Tsimberidou, VR Holley, A Adat, SP Patel, AK Sood, ... Journal of Clinical Oncology 39 (15_suppl), 2558-2558, 2021 | 3 | 2021 |
| Analysis of the effect of systemic corticosteroids on survival from tebentafusp in a phase 3 trial of metastatic uveal melanoma. A Ikeguchi, JJ Sacco, JJ Luke, TRJ Evans, BD Curti, KB Kim, SE Abdullah, ... Journal of Clinical Oncology 40 (16_suppl), 9584-9584, 2022 | 2 | 2022 |
| 843P Long-term survivors on tebentafusp in phase II trial of previously treated patients with metastatic uveal melanoma T Sato, AP Ikeguchi, P Nathan, RD Carvajal, AN Shoushtari, TF Gajewski, ... Annals of Oncology 33, S934-S935, 2022 | 1 | 2022 |
| 382 Targeting innate immunity with BXCL701 in combination with pembrolizumab in patients with advanced solid cancers: phase 2 basket study F Janku, A Tsimberidou, V Holley, A Adat, O Karakuzu, G Call, G Urschel, ... Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020 | 1 | 2020 |
| 157P Phase I expansion of IMC-C103C, a MAGE-A4× CD3 ImmTAC bispecific protein, in ovarian carcinoma R Sweis, E Garralda, OS Santa Gadea, KN Moore, D Davar, O Hamid, ... Immuno-Oncology and Technology 16, 2022 | | 2022 |
| Discovery and Characterization of the Polycomb Repressive Complex 1 of C. Elegans O Karakuzu | | 2009 |
| MIG-32 controls neuronal migration and axon guidance. O Karakuzu, B Prasad, HM Espinoza, C Hernandez, S Cameron International Worm Meeting, 2007 | | 2007 |
| MIG-32, a RING domain protein related to Polycomb family members, controls neuronal migration and axon pathfinding O Karakuzu, B Prasad, H Espinoza, M Ganga, S Cameron Neuronal Development, Synaptic Function, and Behavior Meeting, 2006 | | 2006 |
| Characterization of F11A10. 3, a RING domain protein that interacts with the transcription factor UNC-3 O Karakuzu, B Prasad, S Cameron International Worm Meeting, 2005 | | 2005 |
